Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

48562

	registered interest
	date	25/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, for what reason no risk assessment was made of the care.data programme; and which Minister in his Department authorised not making such an assessment.
	tabling member constituency	Birmingham, Hall Green
	tabling member printed	Mr Roger Godsiff
	uin	196619
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>There has been no decision made not to have a risk assessment for the care.data programme. Risks and issues are considered by the care.data programme board at regular meetings.</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 06/05/2014 12:00:00 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	304 label Biography information for Mr Roger Godsiff

48547

	registered interest
	date	25/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many (a) meetings, (b) items of written correspondence, (c) phone calls, (d) consultation responses, (e) tenders and (f) other individual communications and contacts his Department has had with (i) Johnson & Johnson, (ii) Ethicon and (iii) BARD.
	tabling member constituency	Livingston
	tabling member printed	Graeme Morrice
	uin	196778
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>Within the last 12 months, the Department has had regular communication with a number of pharmaceutical, device and diagnostic manufacturers, on a wide range of topics. However, the information requested could only be provided at disproportionate cost.</p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4012 label Biography information for Graeme Morrice

49331

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many (a) nurses, (b) doctors and (c) surgeons have been employed at (i) Sherwood Forest Hospitals NHS Foundation Trust and (ii) Nottingham University Hospitals in each year since 2007.
	tabling member constituency	Ashfield
	tabling member printed	Gloria De Piero
	uin	197257
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>Information on the number of (a) qualified nursing, midwifery and health visiting staff (b) Hospital and community health service (HCHS) doctors and (c) surgeons employed at (i) Sherwood Forest Hospitals NHS Foundation Trust (FT) and (ii) Nottingham University Hospitals NHS Trust, in each year since 2007 is shown in the attached table.</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 06/05/2014 12:00:00 answering member 3932 label Biography information for Dr Dan Poulter attachment 1 file name PQ197257 table.docx title Table for PQ197257
	tabling member	3915 label Biography information for Gloria De Piero

48589

	registered interest
	date	25/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many adolescents were diagnosed with Type 2 diabetes in (a) 2010-11, (b) 2011-12, (c) 2012-13 and (d) 2013-14.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	196485
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>Neither the Department nor NHS England collect this information centrally.</p><p><strong> </strong></p><p>The majority of adolescents with diabetes have their disease managed through specialist paediatric diabetes services. It is estimated that 97% of children with diabetes have Type 1, 1.5% have Type 2 and 1.5% have other types of diabetes.</p><p> </p><p>There is a National Paediatric Diabetes Audit run by the Royal College of Paediatric and Child Health; more information on this audit can be found at:</p><p> </p><p>www.rcpch.ac.uk/national-paediatric-diabetes-audit-npda</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4036 label Biography information for Luciana Berger

48571

	registered interest
	date	25/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many cases of complications with transvaginal mesh implants have been reported by health professionals in each of the last three years.
	tabling member constituency	Livingston
	tabling member printed	Graeme Morrice
	uin	196741
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The Department of Health does not hold information on the number of patients who have required further operations due to complications with transvaginal mesh implants in each of the last three years or the costs of these operations.</p><p> </p><p>The Department has had two meetings in which polypropylene transvaginal mesh implants were either discussed or on the agenda.</p><p> </p><p>NHS England manages the National Reporting and Learning System (NRLS) for patient safety incident reports from the NHS. NHS England shares incident reports concerning harms arising from medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA).</p><p> </p><p>Manufacturers of medical devices such as transvaginal mesh implants are legally required to report adverse incidents (ie death, serious injury or potential serious injury) involving their devices to the MHRA. General Medical Guidance published in February 2013 makes it clear that clinicians should report medical device incidents to the MHRA, and make information available to patients about how they can report side effects to the MHRA. The MHRA also encourages voluntary reporting of adverse incidents by healthcare workers, carers, patients and members of the public and participates in monthly telephone meetings with regulators in other European Union member states to share information about medical device safety.</p><p> </p><p>The Department is currently engaged in work to assess the effectiveness of existing arrangements for reporting complications relating to transvaginal mesh implants. NHS England is leading this work, which also involves the MHRA, the Royal College of Obstetricians and Gynaecologists, and the relevant professional societies (the British Society of Urogynaecology and the British Association of Urological Surgeons).</p><p> </p><p>Finished Consultant Episodes for women who have received a primary or secondary operative procedure for the insertion of Transvaginal Mesh, Transobturator Tape, Transvaginal Slings and Transvaginal Tape.</p><p> </p><table><tbody><tr><td><p>Procedure</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td></tr><tr><td><p>Insertion of Transvaginal Mesh</p></td><td><p>1,636</p></td><td><p>1,524</p></td><td><p>1,310</p></td></tr><tr><td><p>Insertion of Transobturator Tape</p></td><td><p>5,426</p></td><td><p>4,885</p></td><td><p>4,476</p></td></tr><tr><td><p>Insertion of Transvaginal Sling</p></td><td><p>130</p></td><td><p>134</p></td><td><p>135</p></td></tr><tr><td><p>Insertion of Transvaginal Tape</p></td><td><p>8,087</p></td><td><p>8,172</p></td><td><p>7,627</p></td></tr></tbody></table><p> </p><p><em>Source</em>: Hospital Episode Statistics (HES), Health and Social Care Information Centre.</p><p><em>Note</em>: Activity in English NHS Hospitals and English NHS commissioned activity in the independent sector.</p><p> </p><p> </p><p>Adverse events reported to MHRA by Health Professionals concerning Vaginal tape and mesh implants are as follows</p><p> </p><table><tbody><tr><td> </td><td><p>Vaginal Tapes for Stress Urinary Incontinence</p></td><td><p>Vaginal Mesh for Pelvic Organ Prolapse</p></td><td><p>Vaginal Mesh for unknown* indication</p></td></tr><tr><td><p>2011</p></td><td><p>3</p></td><td><p>1</p></td><td><p>0</p></td></tr><tr><td><p>2012</p></td><td><p>23</p></td><td><p>31</p></td><td><p>2</p></td></tr><tr><td><p>2013</p></td><td><p>27</p></td><td><p>20</p></td><td><p>0</p></td></tr><tr><td><p>Up to March 2014</p></td><td><p>16</p></td><td><p>7</p></td><td><p>0</p></td></tr></tbody></table><p>*The reporter did not provide enough information on what type of mesh it was</p><p> </p><p> </p><p>Number of patient safety incidents relating to mesh used in gynaecological procedures reported to the NRLS (Year of occurrence by reported degree of harm)</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>No Harm</p></td><td><p>Low</p></td><td><p>Moderate</p></td><td><p>TOTAL</p></td></tr><tr><td><p>2011</p></td><td><p>0</p></td><td><p>2</p></td><td><p>4</p></td><td><p>6</p></td></tr><tr><td><p>2012</p></td><td><p>7</p></td><td><p>4</p></td><td><p>3</p></td><td><p>14</p></td></tr><tr><td><p>2013</p></td><td><p>4</p></td><td><p>1</p></td><td><p>1</p></td><td><p>6</p></td></tr><tr><td><p>TOTAL</p></td><td><p>11</p></td><td><p>7</p></td><td><p>8</p></td><td><p>26</p></td></tr></tbody></table><p>Search strategy: All incidents from gynaecological specialties in the NRLS were searched on 2 December 2013 for the keyword ‘mesh'</p><p> </p><p> </p><p> </p><p>Adverse events reported to MHRA by patients/members of the public concerning Vaginal tape and mesh implants are as follows</p><p> </p><table><tbody><tr><td> </td><td><p>Vaginal Tapes for Stress Urinary Incontinence</p></td><td><p>Vaginal Mesh for Pelvic Organ Prolapse</p></td><td><p>Vaginal Mesh for unknown* indication</p></td></tr><tr><td><p>2011</p></td><td><p>33</p></td><td><p>7</p></td><td><p>3</p></td></tr><tr><td><p>2012</p></td><td><p>26</p></td><td><p>2</p></td><td><p>0</p></td></tr><tr><td><p>2013</p></td><td><p>30</p></td><td><p>10</p></td><td><p>3</p></td></tr><tr><td><p>Up to March 2014</p></td><td><p>7</p></td><td><p>0</p></td><td><p>0</p></td></tr></tbody></table><p>*The reporter did not provide enough information on what type of mesh it was</p><p> </p><p>No incidents relating to transvaginal mesh have been reported to the NRLS by patients.</p><p> </p><p>The Department has answered 11 previous Parliamentary Questions, 27 letters from hon. Members and Peers and 17 letters from members of the public since 1 September 2011. The Chief Executive of the MHRA has replied to six letters from hon. Members since 1 September 2011.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 196738 196739 196740 196742 196743 196744 question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4012 label Biography information for Graeme Morrice

48548

	registered interest
	date	25/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many children of each (a) age and (b) gender have died while in-patients (i) at psychiatric hospitals in total as either forcefully detained or voluntary in-patients and (ii) in each institution in each year since 2000.
	tabling member constituency	Feltham and Heston
	tabling member printed	Seema Malhotra
	uin	196781
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>Since April 2008 all Local Safeguarding Children Boards have had a statutory duty to review the death of all children from birth to age 18. Statistics on these Child Death Reviews are collated and published by the Care Quality Commission (CQC) and are available on the CQC's website:</p><p> </p><p>www.gov.uk/government/collections/statistics-child-death-reviews.</p><p> </p><p>Statistics on the location of child deaths are available from 2010 onward and show that in this time, no child has died in an inpatient mental health unit.</p><p> </p><p>According to data from the Mental Health Act Commission, six females and one male under 18 died between 2003 and 2008. Owing to patient confidentiality these figures cannot broken down to each institution.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4253 label Biography information for Seema Malhotra

48236

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many children of what age have spent three months or more continuously in hospital in each local health authority in each of the last five years.
	tabling member constituency	Chatham and Aylesford
	tabling member printed	Tracey Crouch
	uin	196252
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>Information is not available by local health authority. The attached table gives information by strategic health authority (SHA) of the number of children (by age bands) up to 18 years who have spent more than three months in hospital in the last five years for which information is available.</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 06/05/2014 12:00:00 answering member 3932 label Biography information for Dr Dan Poulter attachment 1 file name PQ196252 - Count of Finished Discharge Episodes.docx title Count of Finished Discharge Episodes
	tabling member	3950 label Biography information for Dame Tracey Crouch

49195

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many complaints against GPs have resulted in a GP being struck off by the General Medical Council in the last five years.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	197289
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The General Medical Council (GMC) is an independent body and responsible for dealing firmly and fairly with doctors whose fitness to practise is in doubt. The information in this response has been provided by the GMC.</p><p> </p><p>Table 1 below shows the numbers of complaints against general practitioners (GPs) and the number of investigations resulting from those complaints in each of the last five years. Table 2 shows the number of GPs erased from the register in each of the last five years.</p><p> </p><p>Table 1:</p><table><tbody><tr><td> </td><td> </td><td colspan="2"> </td><td> </td><td colspan="2"> </td></tr><tr><td> </td><td colspan="3"><p><strong>Complaints</strong></p></td><td colspan="3"><p><strong>Investigations</strong></p></td></tr><tr><td> </td><td colspan="2"><p><strong>All Doctors</strong></p></td><td><p><strong>GPs</strong></p></td><td colspan="2"><p><strong>All Doctors</strong></p></td><td><p><strong>GPs</strong></p></td></tr><tr><td><p><strong>2009</strong></p></td><td colspan="2"><p>5,773</p></td><td><p>2,085</p></td><td colspan="2"><p>1,758</p></td><td><p>564</p></td></tr><tr><td><p><strong>2010</strong></p></td><td colspan="2"><p>7,153</p></td><td><p>2,899</p></td><td colspan="2"><p>2,066</p></td><td><p>757</p></td></tr><tr><td><p><strong>2011</strong></p></td><td colspan="2"><p>8,781</p></td><td><p>3,291</p></td><td colspan="2"><p>2,330</p></td><td><p>817</p></td></tr><tr><td><p><strong>2012</strong></p></td><td colspan="2"><p>10,347</p></td><td><p>4,017</p></td><td colspan="2"><p>2,708</p></td><td><p>1,021</p></td></tr><tr><td><p><strong>2013</strong></p></td><td colspan="2"><p>9,866</p></td><td><p>3,530</p></td><td colspan="2"><p>2,939</p></td><td><p>1,098</p></td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr></tbody></table><p> </p><p>Table 2:</p><table><tbody><tr><td> </td><td> </td><td> </td></tr><tr><td> </td><td colspan="2"><p><strong>Erased</strong></p></td></tr><tr><td> </td><td><p><strong>All</strong></p></td><td><p><strong>GPs</strong></p></td></tr><tr><td><p><strong>2009</strong></p></td><td><p>78</p></td><td><p>30</p></td></tr><tr><td><p><strong>2010</strong></p></td><td><p>93</p></td><td><p>35</p></td></tr><tr><td><p><strong>2011</strong></p></td><td><p>77</p></td><td><p>26</p></td></tr><tr><td><p><strong>2012</strong></p></td><td><p>74</p></td><td><p>18</p></td></tr><tr><td><p><strong>2013</strong></p></td><td><p>67</p></td><td><p>18</p></td></tr></tbody></table><p> </p><p><strong> </strong></p><p><strong>Note</strong><strong>:</strong>The number of complaints and investigations are directly related but the number of erasures are not necessarily related or from the same cohort of cases that are received/investigated for the same year given the timing of complaints and final hearings/appeals. Also to note, the GMC changed the way it recorded enquiries in 2013. The GMC no longer record notification around Performers Lists unless there is a wider fitness to practice concern. The numbers are therefore not directly comparable to previous years.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 06/05/2014 12:00:00 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1409 label Biography information for Mr Gregory Campbell

49060

	registered interest
	date	29/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many hospital attendances there were from each prison in each of the last four years.
	tabling member constituency	Tooting
	tabling member printed	Sadiq Khan
	uin	197046
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>This information is not collected centrally by the Department or NHS England.</p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 197047 question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	1577 label Biography information for Sadiq Khan

49061

	registered interest
	date	29/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many hospital attendances there were from the (a) adult male, (b) adult female, (c) youth male, (d) youth female and (e) total prison estate in each of the last four years.
	tabling member constituency	Tooting
	tabling member printed	Sadiq Khan
	uin	197047
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>This information is not collected centrally by the Department or NHS England.</p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 197046 question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	1577 label Biography information for Sadiq Khan

49312

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many of his Department's agencies, non-departmental public bodies or sponsored bodies have developed their own global health strategies.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	197370
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>In addition to the cross-Government global health strategy, <em>Health is Global</em>: An outcome framework for global health 2011-2015, published in 2011, Public Health England is developing a global health strategy.</p><p> </p><p>This will complement, and will be consistent with, <em>Health is Global.</em></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4036 label Biography information for Luciana Berger

48572

	registered interest
	date	25/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many patients have received polypropylene transvaginal mesh implants through the NHS in each of the last three years.
	tabling member constituency	Livingston
	tabling member printed	Graeme Morrice
	uin	196740
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The Department of Health does not hold information on the number of patients who have required further operations due to complications with transvaginal mesh implants in each of the last three years or the costs of these operations.</p><p> </p><p>The Department has had two meetings in which polypropylene transvaginal mesh implants were either discussed or on the agenda.</p><p> </p><p>NHS England manages the National Reporting and Learning System (NRLS) for patient safety incident reports from the NHS. NHS England shares incident reports concerning harms arising from medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA).</p><p> </p><p>Manufacturers of medical devices such as transvaginal mesh implants are legally required to report adverse incidents (ie death, serious injury or potential serious injury) involving their devices to the MHRA. General Medical Guidance published in February 2013 makes it clear that clinicians should report medical device incidents to the MHRA, and make information available to patients about how they can report side effects to the MHRA. The MHRA also encourages voluntary reporting of adverse incidents by healthcare workers, carers, patients and members of the public and participates in monthly telephone meetings with regulators in other European Union member states to share information about medical device safety.</p><p> </p><p>The Department is currently engaged in work to assess the effectiveness of existing arrangements for reporting complications relating to transvaginal mesh implants. NHS England is leading this work, which also involves the MHRA, the Royal College of Obstetricians and Gynaecologists, and the relevant professional societies (the British Society of Urogynaecology and the British Association of Urological Surgeons).</p><p> </p><p>Finished Consultant Episodes for women who have received a primary or secondary operative procedure for the insertion of Transvaginal Mesh, Transobturator Tape, Transvaginal Slings and Transvaginal Tape.</p><p> </p><table><tbody><tr><td><p>Procedure</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td></tr><tr><td><p>Insertion of Transvaginal Mesh</p></td><td><p>1,636</p></td><td><p>1,524</p></td><td><p>1,310</p></td></tr><tr><td><p>Insertion of Transobturator Tape</p></td><td><p>5,426</p></td><td><p>4,885</p></td><td><p>4,476</p></td></tr><tr><td><p>Insertion of Transvaginal Sling</p></td><td><p>130</p></td><td><p>134</p></td><td><p>135</p></td></tr><tr><td><p>Insertion of Transvaginal Tape</p></td><td><p>8,087</p></td><td><p>8,172</p></td><td><p>7,627</p></td></tr></tbody></table><p> </p><p><em>Source</em>: Hospital Episode Statistics (HES), Health and Social Care Information Centre.</p><p><em>Note</em>: Activity in English NHS Hospitals and English NHS commissioned activity in the independent sector.</p><p> </p><p> </p><p>Adverse events reported to MHRA by Health Professionals concerning Vaginal tape and mesh implants are as follows</p><p> </p><table><tbody><tr><td> </td><td><p>Vaginal Tapes for Stress Urinary Incontinence</p></td><td><p>Vaginal Mesh for Pelvic Organ Prolapse</p></td><td><p>Vaginal Mesh for unknown* indication</p></td></tr><tr><td><p>2011</p></td><td><p>3</p></td><td><p>1</p></td><td><p>0</p></td></tr><tr><td><p>2012</p></td><td><p>23</p></td><td><p>31</p></td><td><p>2</p></td></tr><tr><td><p>2013</p></td><td><p>27</p></td><td><p>20</p></td><td><p>0</p></td></tr><tr><td><p>Up to March 2014</p></td><td><p>16</p></td><td><p>7</p></td><td><p>0</p></td></tr></tbody></table><p>*The reporter did not provide enough information on what type of mesh it was</p><p> </p><p> </p><p>Number of patient safety incidents relating to mesh used in gynaecological procedures reported to the NRLS (Year of occurrence by reported degree of harm)</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>No Harm</p></td><td><p>Low</p></td><td><p>Moderate</p></td><td><p>TOTAL</p></td></tr><tr><td><p>2011</p></td><td><p>0</p></td><td><p>2</p></td><td><p>4</p></td><td><p>6</p></td></tr><tr><td><p>2012</p></td><td><p>7</p></td><td><p>4</p></td><td><p>3</p></td><td><p>14</p></td></tr><tr><td><p>2013</p></td><td><p>4</p></td><td><p>1</p></td><td><p>1</p></td><td><p>6</p></td></tr><tr><td><p>TOTAL</p></td><td><p>11</p></td><td><p>7</p></td><td><p>8</p></td><td><p>26</p></td></tr></tbody></table><p>Search strategy: All incidents from gynaecological specialties in the NRLS were searched on 2 December 2013 for the keyword ‘mesh'</p><p> </p><p> </p><p> </p><p>Adverse events reported to MHRA by patients/members of the public concerning Vaginal tape and mesh implants are as follows</p><p> </p><table><tbody><tr><td> </td><td><p>Vaginal Tapes for Stress Urinary Incontinence</p></td><td><p>Vaginal Mesh for Pelvic Organ Prolapse</p></td><td><p>Vaginal Mesh for unknown* indication</p></td></tr><tr><td><p>2011</p></td><td><p>33</p></td><td><p>7</p></td><td><p>3</p></td></tr><tr><td><p>2012</p></td><td><p>26</p></td><td><p>2</p></td><td><p>0</p></td></tr><tr><td><p>2013</p></td><td><p>30</p></td><td><p>10</p></td><td><p>3</p></td></tr><tr><td><p>Up to March 2014</p></td><td><p>7</p></td><td><p>0</p></td><td><p>0</p></td></tr></tbody></table><p>*The reporter did not provide enough information on what type of mesh it was</p><p> </p><p>No incidents relating to transvaginal mesh have been reported to the NRLS by patients.</p><p> </p><p>The Department has answered 11 previous Parliamentary Questions, 27 letters from hon. Members and Peers and 17 letters from members of the public since 1 September 2011. The Chief Executive of the MHRA has replied to six letters from hon. Members since 1 September 2011.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 196738 196739 196741 196742 196743 196744 question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4012 label Biography information for Graeme Morrice

48578

	registered interest
	date	25/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many patients have reported complications with polypropylene transvaginal mesh implants in each of the last three years.
	tabling member constituency	Livingston
	tabling member printed	Graeme Morrice
	uin	196739
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The Department of Health does not hold information on the number of patients who have required further operations due to complications with transvaginal mesh implants in each of the last three years or the costs of these operations.</p><p> </p><p>The Department has had two meetings in which polypropylene transvaginal mesh implants were either discussed or on the agenda.</p><p> </p><p>NHS England manages the National Reporting and Learning System (NRLS) for patient safety incident reports from the NHS. NHS England shares incident reports concerning harms arising from medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA).</p><p> </p><p>Manufacturers of medical devices such as transvaginal mesh implants are legally required to report adverse incidents (ie death, serious injury or potential serious injury) involving their devices to the MHRA. General Medical Guidance published in February 2013 makes it clear that clinicians should report medical device incidents to the MHRA, and make information available to patients about how they can report side effects to the MHRA. The MHRA also encourages voluntary reporting of adverse incidents by healthcare workers, carers, patients and members of the public and participates in monthly telephone meetings with regulators in other European Union member states to share information about medical device safety.</p><p> </p><p>The Department is currently engaged in work to assess the effectiveness of existing arrangements for reporting complications relating to transvaginal mesh implants. NHS England is leading this work, which also involves the MHRA, the Royal College of Obstetricians and Gynaecologists, and the relevant professional societies (the British Society of Urogynaecology and the British Association of Urological Surgeons).</p><p> </p><p>Finished Consultant Episodes for women who have received a primary or secondary operative procedure for the insertion of Transvaginal Mesh, Transobturator Tape, Transvaginal Slings and Transvaginal Tape.</p><p> </p><table><tbody><tr><td><p>Procedure</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td></tr><tr><td><p>Insertion of Transvaginal Mesh</p></td><td><p>1,636</p></td><td><p>1,524</p></td><td><p>1,310</p></td></tr><tr><td><p>Insertion of Transobturator Tape</p></td><td><p>5,426</p></td><td><p>4,885</p></td><td><p>4,476</p></td></tr><tr><td><p>Insertion of Transvaginal Sling</p></td><td><p>130</p></td><td><p>134</p></td><td><p>135</p></td></tr><tr><td><p>Insertion of Transvaginal Tape</p></td><td><p>8,087</p></td><td><p>8,172</p></td><td><p>7,627</p></td></tr></tbody></table><p> </p><p><em>Source</em>: Hospital Episode Statistics (HES), Health and Social Care Information Centre.</p><p><em>Note</em>: Activity in English NHS Hospitals and English NHS commissioned activity in the independent sector.</p><p> </p><p> </p><p>Adverse events reported to MHRA by Health Professionals concerning Vaginal tape and mesh implants are as follows</p><p> </p><table><tbody><tr><td> </td><td><p>Vaginal Tapes for Stress Urinary Incontinence</p></td><td><p>Vaginal Mesh for Pelvic Organ Prolapse</p></td><td><p>Vaginal Mesh for unknown* indication</p></td></tr><tr><td><p>2011</p></td><td><p>3</p></td><td><p>1</p></td><td><p>0</p></td></tr><tr><td><p>2012</p></td><td><p>23</p></td><td><p>31</p></td><td><p>2</p></td></tr><tr><td><p>2013</p></td><td><p>27</p></td><td><p>20</p></td><td><p>0</p></td></tr><tr><td><p>Up to March 2014</p></td><td><p>16</p></td><td><p>7</p></td><td><p>0</p></td></tr></tbody></table><p>*The reporter did not provide enough information on what type of mesh it was</p><p> </p><p> </p><p>Number of patient safety incidents relating to mesh used in gynaecological procedures reported to the NRLS (Year of occurrence by reported degree of harm)</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>No Harm</p></td><td><p>Low</p></td><td><p>Moderate</p></td><td><p>TOTAL</p></td></tr><tr><td><p>2011</p></td><td><p>0</p></td><td><p>2</p></td><td><p>4</p></td><td><p>6</p></td></tr><tr><td><p>2012</p></td><td><p>7</p></td><td><p>4</p></td><td><p>3</p></td><td><p>14</p></td></tr><tr><td><p>2013</p></td><td><p>4</p></td><td><p>1</p></td><td><p>1</p></td><td><p>6</p></td></tr><tr><td><p>TOTAL</p></td><td><p>11</p></td><td><p>7</p></td><td><p>8</p></td><td><p>26</p></td></tr></tbody></table><p>Search strategy: All incidents from gynaecological specialties in the NRLS were searched on 2 December 2013 for the keyword ‘mesh'</p><p> </p><p> </p><p> </p><p>Adverse events reported to MHRA by patients/members of the public concerning Vaginal tape and mesh implants are as follows</p><p> </p><table><tbody><tr><td> </td><td><p>Vaginal Tapes for Stress Urinary Incontinence</p></td><td><p>Vaginal Mesh for Pelvic Organ Prolapse</p></td><td><p>Vaginal Mesh for unknown* indication</p></td></tr><tr><td><p>2011</p></td><td><p>33</p></td><td><p>7</p></td><td><p>3</p></td></tr><tr><td><p>2012</p></td><td><p>26</p></td><td><p>2</p></td><td><p>0</p></td></tr><tr><td><p>2013</p></td><td><p>30</p></td><td><p>10</p></td><td><p>3</p></td></tr><tr><td><p>Up to March 2014</p></td><td><p>7</p></td><td><p>0</p></td><td><p>0</p></td></tr></tbody></table><p>*The reporter did not provide enough information on what type of mesh it was</p><p> </p><p>No incidents relating to transvaginal mesh have been reported to the NRLS by patients.</p><p> </p><p>The Department has answered 11 previous Parliamentary Questions, 27 letters from hon. Members and Peers and 17 letters from members of the public since 1 September 2011. The Chief Executive of the MHRA has replied to six letters from hon. Members since 1 September 2011.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 196738 196740 196741 196742 196743 196744 question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4012 label Biography information for Graeme Morrice

48539

	registered interest
	date	25/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many patients have required further operations due to complications with transvaginal mesh implants in each of the last three years; and what the cost of such procedures was.
	tabling member constituency	Livingston
	tabling member printed	Graeme Morrice
	uin	196743
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The Department of Health does not hold information on the number of patients who have required further operations due to complications with transvaginal mesh implants in each of the last three years or the costs of these operations.</p><p> </p><p>The Department has had two meetings in which polypropylene transvaginal mesh implants were either discussed or on the agenda.</p><p> </p><p>NHS England manages the National Reporting and Learning System (NRLS) for patient safety incident reports from the NHS. NHS England shares incident reports concerning harms arising from medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA).</p><p> </p><p>Manufacturers of medical devices such as transvaginal mesh implants are legally required to report adverse incidents (ie death, serious injury or potential serious injury) involving their devices to the MHRA. General Medical Guidance published in February 2013 makes it clear that clinicians should report medical device incidents to the MHRA, and make information available to patients about how they can report side effects to the MHRA. The MHRA also encourages voluntary reporting of adverse incidents by healthcare workers, carers, patients and members of the public and participates in monthly telephone meetings with regulators in other European Union member states to share information about medical device safety.</p><p> </p><p>The Department is currently engaged in work to assess the effectiveness of existing arrangements for reporting complications relating to transvaginal mesh implants. NHS England is leading this work, which also involves the MHRA, the Royal College of Obstetricians and Gynaecologists, and the relevant professional societies (the British Society of Urogynaecology and the British Association of Urological Surgeons).</p><p> </p><p>Finished Consultant Episodes for women who have received a primary or secondary operative procedure for the insertion of Transvaginal Mesh, Transobturator Tape, Transvaginal Slings and Transvaginal Tape.</p><p> </p><table><tbody><tr><td><p>Procedure</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td></tr><tr><td><p>Insertion of Transvaginal Mesh</p></td><td><p>1,636</p></td><td><p>1,524</p></td><td><p>1,310</p></td></tr><tr><td><p>Insertion of Transobturator Tape</p></td><td><p>5,426</p></td><td><p>4,885</p></td><td><p>4,476</p></td></tr><tr><td><p>Insertion of Transvaginal Sling</p></td><td><p>130</p></td><td><p>134</p></td><td><p>135</p></td></tr><tr><td><p>Insertion of Transvaginal Tape</p></td><td><p>8,087</p></td><td><p>8,172</p></td><td><p>7,627</p></td></tr></tbody></table><p> </p><p><em>Source</em>: Hospital Episode Statistics (HES), Health and Social Care Information Centre.</p><p><em>Note</em>: Activity in English NHS Hospitals and English NHS commissioned activity in the independent sector.</p><p> </p><p> </p><p>Adverse events reported to MHRA by Health Professionals concerning Vaginal tape and mesh implants are as follows</p><p> </p><table><tbody><tr><td> </td><td><p>Vaginal Tapes for Stress Urinary Incontinence</p></td><td><p>Vaginal Mesh for Pelvic Organ Prolapse</p></td><td><p>Vaginal Mesh for unknown* indication</p></td></tr><tr><td><p>2011</p></td><td><p>3</p></td><td><p>1</p></td><td><p>0</p></td></tr><tr><td><p>2012</p></td><td><p>23</p></td><td><p>31</p></td><td><p>2</p></td></tr><tr><td><p>2013</p></td><td><p>27</p></td><td><p>20</p></td><td><p>0</p></td></tr><tr><td><p>Up to March 2014</p></td><td><p>16</p></td><td><p>7</p></td><td><p>0</p></td></tr></tbody></table><p>*The reporter did not provide enough information on what type of mesh it was</p><p> </p><p> </p><p>Number of patient safety incidents relating to mesh used in gynaecological procedures reported to the NRLS (Year of occurrence by reported degree of harm)</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>No Harm</p></td><td><p>Low</p></td><td><p>Moderate</p></td><td><p>TOTAL</p></td></tr><tr><td><p>2011</p></td><td><p>0</p></td><td><p>2</p></td><td><p>4</p></td><td><p>6</p></td></tr><tr><td><p>2012</p></td><td><p>7</p></td><td><p>4</p></td><td><p>3</p></td><td><p>14</p></td></tr><tr><td><p>2013</p></td><td><p>4</p></td><td><p>1</p></td><td><p>1</p></td><td><p>6</p></td></tr><tr><td><p>TOTAL</p></td><td><p>11</p></td><td><p>7</p></td><td><p>8</p></td><td><p>26</p></td></tr></tbody></table><p>Search strategy: All incidents from gynaecological specialties in the NRLS were searched on 2 December 2013 for the keyword ‘mesh'</p><p> </p><p> </p><p> </p><p>Adverse events reported to MHRA by patients/members of the public concerning Vaginal tape and mesh implants are as follows</p><p> </p><table><tbody><tr><td> </td><td><p>Vaginal Tapes for Stress Urinary Incontinence</p></td><td><p>Vaginal Mesh for Pelvic Organ Prolapse</p></td><td><p>Vaginal Mesh for unknown* indication</p></td></tr><tr><td><p>2011</p></td><td><p>33</p></td><td><p>7</p></td><td><p>3</p></td></tr><tr><td><p>2012</p></td><td><p>26</p></td><td><p>2</p></td><td><p>0</p></td></tr><tr><td><p>2013</p></td><td><p>30</p></td><td><p>10</p></td><td><p>3</p></td></tr><tr><td><p>Up to March 2014</p></td><td><p>7</p></td><td><p>0</p></td><td><p>0</p></td></tr></tbody></table><p>*The reporter did not provide enough information on what type of mesh it was</p><p> </p><p>No incidents relating to transvaginal mesh have been reported to the NRLS by patients.</p><p> </p><p>The Department has answered 11 previous Parliamentary Questions, 27 letters from hon. Members and Peers and 17 letters from members of the public since 1 September 2011. The Chief Executive of the MHRA has replied to six letters from hon. Members since 1 September 2011.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 196738 196739 196740 196741 196742 196744 question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	4012 label Biography information for Graeme Morrice

49346

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many private abortion clinics are situated on the premises of NHS hospitals in England; and how many such clinics are run by (a) BPAS and (b) Marie Stopes International.
	tabling member constituency	South West Bedfordshire
	tabling member printed	Andrew Selous
	uin	197322
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>There are 17 independent abortion clinics situated on National Health Service premises in England. Of these, 11 are run by the British Pregnancy Advisory Service and three by Marie Stopes International.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	1453 label Biography information for Andrew Selous

49056

	registered interest
	date	29/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many surgical care practitioners have practised in the NHS in each year since 2005.
	tabling member constituency	Bristol North West
	tabling member printed	Charlotte Leslie
	uin	196994
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p /> <p /> <p>The information is not held centrally. The number of surgical care practitioners who have practised in the National Health Service in each year since 2005 are not identified separately in the annual NHS workforce census.</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 06/05/2014 12:00:00 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	3933 label Biography information for Charlotte Leslie

49274

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much (a) NHS England, (b) Clinical Commissioning Groups, (c) Commissioning Support Units and (d) Monitor spent on consultancy workers in the last financial year.
	tabling member constituency	Copeland
	tabling member printed	Mr Jamie Reed
	uin	197320
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>As final year accounts have not yet been produced for Monitor or for NHS England, it is not at this time possible to give actual spend figures for 2013-14.</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 06/05/2014 12:00:00 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1503 label Biography information for Mr Jamie Reed

49273

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much NHS England spent on tendering for clinical services in 2013-14.
	tabling member constituency	Copeland
	tabling member printed	Mr Jamie Reed
	uin	197353
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>NHS England has advised that it does not hold information on spend on tendering for clinical services. Staff payroll costs will form the majority of the cost of any tendering process and it is not possible to determine what proportion of each individual staff member's time is spent on this work.</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 06/05/2014 12:00:00 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1503 label Biography information for Mr Jamie Reed

49313

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much Public Health England has spent on consultancy workers in 2013-14.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	197371
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>Public Health England (PHE) has incurred no expenditure with professional consultancy firms of the nature described in the Cabinet Office definition of Consultancy.</p><p><strong> </strong></p><p>However, PHE sought approval under the Department's Professional Services approvals route for £8.1million of contingent labour where the daily rate of the individuals concerned was more than £220 per day. This involves approval by the Chief Executive of PHE, by the Department's Procurement and by the Department's Financial Approvals Panel.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4036 label Biography information for Luciana Berger

49311

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much Public Health England has spent on the development and implementation of its Global Health Strategy since its inception.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	197369
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>Public Health England's (PHE) Global Health Strategy is currently in development.</p><p>Development of the strategy has been undertaken by PHE's in-house global health and international teams. The following table shows PHE's spend on the development of its Global Health Strategy:</p><p> </p><p> </p><table><tbody><tr><td><p>Expense</p></td><td><p>Cost (£)</p></td></tr><tr><td><p>Staff time attributed to strategy development *</p></td><td><p>41,783.63</p></td></tr><tr><td><p>Travel expenses</p></td><td><p>348.05</p></td></tr><tr><td><p>Off-site meeting in UK</p></td><td><p>1,407.71</p></td></tr><tr><td><p>Total **</p></td><td><p>43,539.39</p></td></tr></tbody></table><p> </p><p><em>Notes:</em></p><p>*Staff time includes the contribution from a consultant in public health plus employer related costs. This excludes other staff contributions for which time allocation is not captured.</p><p>**Excludes telephony costs and minor refreshments costs.</p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4036 label Biography information for Luciana Berger

48282

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how the National Institute for Health and Care Excellence (NICE) assesses the cost-effectiveness of an intervention when the data available are uncertain; what assessment NICE has made of the average range around the most-plausible cost-per-QALY in its technology appraisals; and if he will make a statement.
	tabling member constituency	Eddisbury
	tabling member printed	Mr Stephen O'Brien
	uin	196424
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The National Institute for Health and Care Excellence (NICE) follows a rigorous process in the appraisal of technologies to ensure that judgements regarding the cost-effective use of NHS resources are consistently applied. This includes consideration of the uncertainty generated where available data have serious limitations.</p><p> </p><p>When making judgements on cost effectiveness, the NICE appraisal committee will consider a number of factors including the strength of the clinical-effectiveness evidence, the innovative nature of the technology, the robustness and plausibility of the economic models, the degree of certainty around the incremental cost-effectiveness ratio (ICER), the range and plausibility of the ICERs and the likelihood of decision error and its consequences. Full details of how the Committee takes uncertainty into account is contained within sections 5.8, 6.3 and 6.4 of NICE's Guide to the Methods of Technology Appraisal 2013, which is available at:</p><p>http://publications.nice.org.uk/guide-to-the-methods-of-technology-appraisal-2013-pmg9</p><p> </p><p>NICE advises that it has not carried out an assessment of the average range around the most plausible cost-per Quality Adjusted Life Year (QALY) in its technology appraisals. We understand that although NICE usually specifies the most plausible cost-per-QALY for each technology appraisal, it does not normally specify a range for this assessment.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	427 label Biography information for Mr Stephen O'Brien

48249

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will bring forward from 42 weeks the period for inducing labour in at risk expectant mothers.
	tabling member constituency	Chatham and Aylesford
	tabling member printed	Tracey Crouch
	uin	196280
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p /> <p /> <p>The induction of labour is a clinical decision for healthcare professionals. These decisions are based on the latest available evidence and take account of the risk and other clinical factors for each individual pregnancy.</p><p> </p><p>To assist healthcare professionals, the National Institute for Health and Care Excellence has published clinical guidelines on the induction of labour, which are available on the NICE website at:</p><p> </p><p>www.nice.org.uk/nicemedia/live/12012/41256/41256.pdf.</p><p> </p><p>The NICE guidelines advise that women with uncomplicated pregnancies should usually be offered induction of labour between 41+0 and 42+0 weeks.</p><p> </p><p>Women can be deemed high risk for a multitude of reasons. Each reason will carry its own set of criteria for delivery. It is not possible to say that induction for all at risk pregnancies should be brought forward as these should be reviewed according to individual needs.</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 06/05/2014 12:00:00 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	3950 label Biography information for Dame Tracey Crouch

48243

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will consider creating the role of bereavement midwives to work exclusively with parents who have experienced the death of their baby shortly before, during or after birth; and if he will make a statement.
	tabling member constituency	Chatham and Aylesford
	tabling member printed	Tracey Crouch
	uin	196273
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>It is for the National Health Service locally to ensure appropriate facilities and services are in place to support bereaved parents following the death of a baby. In line with the Nursing and Midwifery Council's Standards of proficiency for pre-registration midwifery education, all midwives should be proficient in providing care for women who have suffered pregnancy loss, stillbirth or neonatal death.</p><p> </p><p>To assist NHS commissioners and providers, the Royal College of Obstetricians and Gynaecologists' <em>Standards for Gynaecology</em> and <em>Standards for Maternity</em> sets out clear standards for the level of care provided to help women and their partners experiencing pregnancy loss, including the availability of skilled staff to support parents following a stillbirth or miscarriage. A number of trusts now employ specialist bereavement midwives to provide this support.</p><p> </p><p>Local NHS maternity care providers are responsible for ensuring parents receive appropriate information on bereavement support and services following the death of a baby. To complement information provided locally, information on support for parents after a stillbirth is available on the NHS Choices website at:</p><p> </p><p>http://www.nhs.uk/Conditions/Stillbirth/Pages/Getting-help.aspx</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter grouped question UIN 196274 question first answered 06/05/2014 12:00:00 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	3950 label Biography information for Dame Tracey Crouch

48281

	registered interest
	date	10/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will discuss with the National Institute for Health and Care Excellence (NICE) ensuring that assessments of treatments by NICE conducted through (a) normal technology appraisals and (b) highly specialised technology appraisals is consistent in its (i) engagement with stakeholders and (ii) wider methodological approaches.
	tabling member constituency	Eddisbury
	tabling member printed	Mr Stephen O'Brien
	uin	196428
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>We have no plans to do so. As an independent body, the National Institute for Health and Care Excellence is responsible for developing its methods and processes and applying them consistently.</p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb
	tabling member	427 label Biography information for Mr Stephen O'Brien

48552

	registered interest
	date	25/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will take steps to transpose quality statements 1 and 2 of the NICE quality standard on psoriasis into Clinical Commissioning Group Outcome Indicators.
	tabling member constituency	Chesham and Amersham
	tabling member printed	Mrs Cheryl Gillan
	uin	196785
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>I refer the right hon. Member to the Written Answer I gave her on 9 April 2014, <em>Official Report</em>, column 262-63W.</p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 196784 question first answered 06/05/2014 12:00:00 answering member 1439 label Biography information for Norman Lamb attachment 1 file name Answer of 9 April - Hansard Extract.docx title Answer of 9 April Hansard Extract column 26263W
	tabling member	18 label Biography information for Dame Cheryl Gillan